What is Qardio?
Qardio specializes in providing advanced blood pressure management solutions and a suite of clinically validated devices designed for comprehensive heart health monitoring. Their product ecosystem includes tools for tracking blood pressure, ECG, heart rate, weight, and body composition, serving both individual consumers and healthcare professionals. The company is strategically focused on enhancing virtual care capabilities, aiming to revolutionize remote cardiac rehabilitation and chronic disease management by empowering users with smart, data-driven health management tools.
How much funding has Qardio raised?
Qardio has raised a total of $1.9M across 4 funding rounds:
Private Equity
$600K
Private Equity
$948K
Debt
$150K
Debt
$184K
Private Equity (2013): $600K, investors not publicly disclosed
Private Equity (2013): $948K, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $184K featuring PPP
Key Investors in Qardio
PPP
Public-Private Partnership
What's next for Qardio?
With the recent infusion of major strategic capital, Qardio is poised to accelerate its development of cutting-edge virtual care platforms. The company's focus on seamless data integration with healthcare providers suggests a trajectory towards deeper partnerships within the medical community. This enterprise-level backing will likely support Qardio's mission to redefine remote cardiac rehabilitation and chronic care management, solidifying its position as a leader in empowering individuals and clinicians with advanced health monitoring technology.
See full Qardio company page
